A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer
A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer. // Gynecologic Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0090825826021815?dgcid=rss_sd_all
A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer. Gynecologic Oncology. https://www.sciencedirect.com/science/article/pii/S0090825826021815?dgcid=rss_sd_all
“A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer.” Gynecologic Oncology.
@article{article47174,
title = {A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer},
journal = {Gynecologic Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0090825826021815?dgcid=rss_sd_all}
}